KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Exact Sciences (EXAS) over the last 15 years, with Q4 2025 value amounting to $15.2 million.

  • Exact Sciences' Other Accumulated Expenses fell 5969.81% to $15.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.2 million, marking a year-over-year decrease of 5969.81%. This contributed to the annual value of $15.2 million for FY2025, which is 5969.81% down from last year.
  • According to the latest figures from Q4 2025, Exact Sciences' Other Accumulated Expenses is $15.2 million, which was down 5969.81% from $14.3 million recorded in Q3 2025.
  • Exact Sciences' 5-year Other Accumulated Expenses high stood at $50.6 million for Q1 2021, and its period low was $8.8 million during Q1 2023.
  • Its 5-year average for Other Accumulated Expenses is $26.9 million, with a median of $29.5 million in 2021.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 78677.53% in 2021, then plummeted by 6956.05% in 2023.
  • Exact Sciences' Other Accumulated Expenses (Quarter) stood at $31.0 million in 2021, then plummeted by 66.91% to $10.2 million in 2022, then skyrocketed by 44.63% to $14.8 million in 2023, then soared by 154.77% to $37.8 million in 2024, then plummeted by 59.7% to $15.2 million in 2025.
  • Its Other Accumulated Expenses stands at $15.2 million for Q4 2025, versus $14.3 million for Q3 2025 and $16.1 million for Q2 2025.